KRISTEN ROBERTS: Open Payments
NPI 1023627122 · GREENVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 13 payments from 8 companies in 2025. Trend: 2023 $223 · 2024 $20 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Aurinia Pharma U.S., Inc. | 1 | $14 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
Products named: IBSRELA, FARXIGA, JARDIANCE, Ozempic, Fabhalta, PURIFIED CORTROPHIN GEL, LUPKYNIS, VELPHORO.
Industry payments across MS — which companies pay providers there.
